2. Search Result
Search Result
Results for "

nitroimidazole

" in MedChemExpress (MCE) Product Catalog:

53

Inhibitors & Agonists

2

Biochemical Assay Reagents

4

Peptides

6

Natural
Products

10

Isotope-Labeled Compounds

2

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-78644
    4-Nitroimidazole

    		Biochemical Assay Reagents Others
    4-Nitroimidazole is a biochemical reagent that can be used as a biological material or organic compound for life science related research.
    4-Nitroimidazole
  • HY-N0195
    Azomycin

    2-nitroimidazole

    		 Bacterial Antibiotic Infection
    Azomycin (2-Nitroimidazole) is an antibiotic which can be active against aerobic Gram-positive and Gram-negative bacteria.
    Azomycin
  • HY-B1244
    Dimetridazole
    1 Publications Verification

    1,2-Dimethyl-5-nitroimidazole

    		 Parasite Antibiotic Infection
    Dmetridazole (1,2-Dimethyl-5-nitroimidazole), a nitroimidazole-based antibiotic, combats protozoan infections .
    Dimetridazole
  • HY-W094047
    5-Chloro-1-methyl-4-nitroimidazole

    		Biochemical Assay Reagents Others
    5-Chloro-1-methyl-4-nitroimidazole is a biochemical reagent that can be used as a biological material or organic compound for life science related research.
    5-Chloro-1-methyl-4-nitroimidazole
  • HY-136436
    Ternidazole hydrochloride

    		Endogenous Metabolite Others
    Ternidazole hydrochloride is a hydroxymetabolite of nitroimidazole, has antiprotozoic properties .
    Ternidazole hydrochloride
  • HY-B1244S
    Dimetridazole-d3

    1,2-Dimethyl-5-nitroimidazole-d3

    		 Parasite Antibiotic Infection
    Dimetridazole-d3 is a deuterium labeled Dimetridazole. Dmetridazole, a nitroimidazole-based antibiotic, combats protozoan infections[1].
    Dimetridazole-d3
  • HY-W008216
    HMMNI

    Hydroxy Dimetridazole

    		 Drug Metabolite Others
    HMMNI (Hydroxy dimetridazole) is a hydroxy metabolite of Dimetridazole. Dimetridazole is a nitroimidazole class drug that combats protozoan infections .
    HMMNI
  • HY-W008216S
    HMMNI-d3

    Hydroxy Dimetridazole-d3

    		 Drug Metabolite Isotope-Labeled Compounds Infection
    HMMNI-d3 is deuterium labeled HMMNI. HMMNI (Hydroxy dimetridazole) is a hydroxy metabolite of Dimetridazole. Dimetridazole is a nitroimidazole class agent that combats protozoan infections[1].
    HMMNI-d3
  • HY-136440
    Hydroxymetronidazole

    Metronidazole-OH

    		 Bacterial Parasite Infection
    Hydroxymetronidazole (Metronidazole-OH) is a metabolite of Metronidazole belonging to the class of nitroimidazoles. Hydroxymetronidazole can be used for the research of certain bacterial and protozoal diseases in poultry, swine dysentery and genital trichomoniasis in cattle .
    Hydroxymetronidazole
  • HY-119900
    Carnidazole

    		Parasite Antibiotic Infection
    Carnidazole is an antiprotozoal agent of the nitroimidazole class. Carnidazole is used for the research of Trichomonas infection .
    Carnidazole
  • HY-W008216R
    HMMNI (Standard)

    		Drug Metabolite Others
    HMMNI (Standard) is the analytical standard of HMMNI. This product is intended for research and analytical applications. HMMNI (Hydroxy dimetridazole) is a hydroxy metabolite of Dimetridazole. Dimetridazole is a nitroimidazole class drug that combats protozoan infections .
    HMMNI (Standard)
  • HY-136440S1
    Hydroxymetronidazole-d2

    Metronidazole-OH-d2

    		 Isotope-Labeled Compounds Infection
    Hydroxymetronidazole-d2 is the deuterium labeled Hydroxymetronidazole(HY-136440).Hydroxymetronidazole (Metronidazole-OH) is a metabolite of Metronidazole belonging to the class of nitroimidazoles. Hydroxymetronidazole can be used for the research of certain bacterial and protozoal diseases in poultry, swine dysentery and genital trichomoniasis in cattle .
    Hydroxymetronidazole-d2
  • HY-13801
    Fexinidazole

    HOE 239

    		 Parasite Infection
    Fexinidazole (HOE 239) is an orally active, potent nitroimidazole antitrypanosomal agent. Fexinidazole shows trypanocidal activity against T. brucei subspecies and strains with IC50s of 0.7-3.3 μM (0.2-0.9 μg/ml). Fexinidazol has the potential for human sleeping sickness (HAT) caused by infection with T. brucei .
    Fexinidazole
  • HY-13801R
    Fexinidazole (Standard)

    		Parasite Infection
    Fexinidazole (Standard) is the analytical standard of Fexinidazole. This product is intended for research and analytical applications. Fexinidazole (HOE 239) is an orally active, potent nitroimidazole antitrypanosomal agent. Fexinidazole shows trypanocidal activity against T. brucei subspecies and strains with IC50s of 0.7-3.3 μM (0.2-0.9 μg/ml). Fexinidazol has the potential for human sleeping sickness (HAT) caused by infection with T. brucei .
    Fexinidazole (Standard)
  • HY-B0992
    Nithiamide
    2 Publications Verification

    CL-5279; Aminitrozole

    		 Bacterial Antibiotic Infection
    Nithiamide is a non-5-nitroimidazole drugs, is a antibiotic used in veterinary.
    Nithiamide
  • HY-123019
    RA-263

    		Others Cancer
    RA-263, a 2-nitroimidazole nucleoside, is an effective radiosensitizer .
    RA-263
  • HY-B0508
    Ornidazole
    2 Publications Verification

    Ro 7-0207

    		 Bacterial Parasite Antibiotic Infection Cancer
    Ornidazole(Ro 7-0207) is a 5-nitroimidazole derivative with antiprotozoal and antibacterial properties against anaerobic bacteria.
    Ornidazole
  • HY-B0177
    Tinidazole
    1 Publications Verification

    		 Bacterial Antibiotic Parasite Infection Cancer
    Tinidazole, an orally available antibacterial agent, is a 5-nitroimidazole with selective activity against anaerobic bacteria and protozoa .
    Tinidazole
  • HY-U00118
    EF-5

    		Others Cancer
    EF-5 (EF5; 2-Nitroimidazole) is a hypoxia labeling agent used to identify hypoxia in cells.
    EF-5
  • HY-116972
    Etanidazole

    SR 2508

    		 Others Cancer
    Etanidazole (SR 2508), a 2-nitroimidazole compound, is a hypoxic radiosensitizer used in cancer diagnosis and chemotherapy research .
    Etanidazole
  • HY-107030
    Nitrefazole

    EMD-15700

    		 Aldehyde Dehydrogenase (ALDH) Metabolic Disease
    Nitrefazole is a 4-nitroimidazole derivative with strong and long lasting inhibition of aldehyde dehydrogenase (ALDH), an enzyme involved in the metabolism of alcohol.
    Nitrefazole
  • HY-18715
    Ornidazole (Levo-)

    (S)-Ornidazole; Levornidazole

    		 Bacterial Parasite Infection
    Ornidazole Levo- is the levo-isomer of Ornidazole. Ornidazole is a 5-nitroimidazole derivative with antiprotozoal and antibacterial properties against anaerobic bacteria. Ornidazole Levo- is the less active isomer.
    Ornidazole (Levo-)
  • HY-B0177S
    Tinidazole-d5

    		Bacterial Infection
    Tinidazole-d5 is the deuterium labeled Tinidazole. Tinidazole, an orally available antibacterial agent, is a 5-nitroimidazole with selective activity against anaerobic bacteria and protozoa[1].
    Tinidazole-d5
  • HY-B0177R
    Tinidazole (Standard)

    		Bacterial Antibiotic Parasite Infection Cancer
    Tinidazole (Standard) is the analytical standard of Tinidazole. This product is intended for research and analytical applications. Tinidazole, an orally available antibacterial agent, is a 5-nitroimidazole with selective activity against anaerobic bacteria and protozoa .
    Tinidazole (Standard)
  • HY-B0508S1
    Ornidazole-13C2,15N2

    Ro 7-0207-13C2,15N2

    		 Isotope-Labeled Compounds Bacterial Parasite Antibiotic Infection
    Ornidazole- 13C2, 15N2 is the 13C, 15N labeled Ornidazole. Ornidazole(Ro 7-0207) is a 5-nitroimidazole derivative with antiprotozoal and antibacterial properties against anaerobic bacteria.
    Ornidazole-13C2,15N2
  • HY-16349
    Nimorazole
    1 Publications Verification

    K-1900

    		 Parasite Antibiotic Infection Cancer
    Nimorazole (K-1900), a 2-nitroimidazole, is a hypoxic cell-radiation sensitizer. Nimorazole has anti-infective and anti-protozoal against trichomoniasis. Nimorazole has the potential for head and neck cancer .
    Nimorazole
  • HY-15781
    Morinidazole
    1 Publications Verification

    		 Bacterial Infection
    Morinidazole is an orally active and 5-nitroimidazole antimicrobial agent that undergoes extensive metabolism in humans via N +-glucuronidation and sulfation. Morinidazole can be used for bacterial infections research including appendicitis and pelvic inflammatory disease (PID) caused by anaerobic bacteria .
    Morinidazole
  • HY-15781A
    (R)-Morinidazole

    		Bacterial Infection
    (R)-Morinidazole is an orally active and 5-nitroimidazole antimicrobial agent that undergoes extensive metabolism in humans via N +-glucuronidation and sulfation. (R)-Morinidazole can be used for bacterial infections research including appendicitis and pelvic inflammatory disease (PID) caused by anaerobic bacteria .
    (R)-Morinidazole
  • HY-16349R
    Nimorazole (Standard)

    		Parasite Antibiotic Infection Cancer
    Nimorazole (Standard) is the analytical standard of Nimorazole. This product is intended for research and analytical applications. Nimorazole (K-1900), a 2-nitroimidazole, is a hypoxic cell-radiation sensitizer. Nimorazole has anti-infective and anti-protozoal against trichomoniasis. Nimorazole has the potential for head and neck cancer .
    Nimorazole (Standard)
  • HY-136436S
    Ternidazole-d6 hydrochloride

    		Endogenous Metabolite Others
    Ternidazole-d6 (hydrochloride) is the deuterium labeled Ternidazole hydrochloride. Ternidazole hydrochloride is a hydroxymetabolite of nitroimidazole, has antiprotozoic properties[1][2].
    Ternidazole-d6 hydrochloride
  • HY-B0318S1
    Metronidazole-d4

    		Bacterial Parasite Apoptosis Antibiotic Infection
    Metronidazole-d4 is the deuterium labeled Metronidazole. Metronidazole is a nitroimidazole antibiotic medication used particularly for anaerobic bacteria and protozoa.
    Metronidazole-d4
  • HY-135212
    Hydroxy ipronidazole

    		Endogenous Metabolite Metabolic Disease
    Hydroxy ipronidazole (Ipronidazole-OH) is a metabolite of nitroimidazole antibiotics, such as ipronidazole (IPZ). Hydroxy ipronidazole may has similar mutagenic potential as the parent compound .
    Hydroxy ipronidazole
  • HY-B0318
    Metronidazole
    Maximum Cited Publications
    27 Publications Verification

    		 Bacterial Parasite Apoptosis Antibiotic Infection Inflammation/Immunology Cancer
    Metronidazole is an orally active nitroimidazole antibiotic. Metronidazole can cross blood brain barrier. Metronidazole can be used for the research of anaerobic infections .
    Metronidazole
  • HY-115249
    Metronidazole acetic acid

    		Bacterial Parasite Antibiotic Infection
    Metronidazole acetic acid is a metabolite of Metronidazole with mutagenic activity in bacteria. Metronidazole is a nitroimidazole antibiotic, amebicide, and antiprotozoal agent used particularly for anaerobic bacteria and protozoa .
    Metronidazole acetic acid
  • HY-P4561
    H-Pro-Thr-Glu-Phe-p-nitro-Phe-Arg-Leu-OH

    		Cathepsin Others
    H-Pro-Thr-Glu-Phe-p-nitro-Phe-Arg-Leu-OH is a water-soluble polypeptide that can serve as a substrate for cathepsin D, pepsin and pepsinogen. H-Pro-Thr-Glu-Phe-p-nitro-Phe-Arg-Leu-OH has potential applications in biochemical analysis .
    H-Pro-Thr-Glu-Phe-p-nitro-Phe-Arg-Leu-OH
  • HY-B0318S
    Metronidazole-13C2,15N2

    		Bacterial Parasite Apoptosis Antibiotic Infection
    Metronidazole- 13C2, 15N2 is the 13C-labeled and 15N-labeled Metronidazole. Metronidazole is a nitroimidazole antibiotic medication used particularly for anaerobic bacteria and protozoa.
    Metronidazole-13C2,15N2
  • HY-163925
    Lu-AAZTA-NI-PSMA-093

    		Others Cancer
    Lu-AAZTA-NI-PSMA-093 is a bivalent radiopharmaceutical agent for prostate cancer, that enhances tumor uptake and retention by combining a hypoxia-sensitive nitroimidazole (NI) moiety with a targeting moiety to PSMA .
    Lu-AAZTA-NI-PSMA-093
  • HY-P4556
    H-Phe-Gly-His-p-nitro-Phe-Phe-Ala-Phe-OMe

    		Biochemical Assay Reagents Others
    H-Phe-Gly-His-p-nitro-Phe-Phe-Ala-Phe-OMe is a polypeptide that can be hydrolyzed by Rennin (HY-P2810). H-Phe-Gly-His-p-nitro-Phe-Phe-Ala-Phe-OMe is commonly used as a biochemical reaction reagent .
    H-Phe-Gly-His-p-nitro-Phe-Phe-Ala-Phe-OMe
  • HY-135212S
    Hydroxy ipronidazole-d3

    		Endogenous Metabolite Metabolic Disease
    Hydroxy ipronidazole-d3 is the deuterium labeled Hydroxy ipronidazole. Hydroxy ipronidazole (Ipronidazole-OH) is a metabolite of nitroimidazole antibiotics, such as ipronidazole (IPZ). Hydroxy ipronidazole may has similar mutagenic potential as the parent compound[1].
    Hydroxy ipronidazole-d3
  • HY-163545
    Tc-Me2P

    		Others Cancer
    Tc-Me2P is a 99MTC-labeled acrylamide (PnAO) derivative that contains two 4-methyl-2-nitroimidazole groups. The primary activity of Tc-Me2P is as an imaging agent for tumor hypoxia. By specifically binding to hypoxic regions in tumor tissue, it can be used for single photon emission computed tomography (SPECT) and positron emission tomography (PET) imaging to detect hypoxia in tumors. Tc-Me2P can be used to study the targeting of different chemical structures in tumors and normal tissues .
    Tc-Me2P
  • HY-136440S
    Hydroxymetronidazole-d4

    Metronidazole-OH-d4

    		 Isotope-Labeled Compounds Bacterial Parasite Infection
    Hydroxymetronidazole-d4 is the deuterium labeled Hydroxymetronidazole. Hydroxymetronidazole (Metronidazole-OH) is a metabolite of Metronidazole belonging to the class of nitroimidazoles. Hydroxymetronidazole can be used for the research of certain bacterial and protozoal diseases in poultry, swine dysentery and genital trichomoniasis in cattle[1].
    Hydroxymetronidazole-d4
  • HY-B0318A
    Metronidazole hydrochloride

    SC 326421

    		 Antibiotic Bacterial Parasite Apoptosis Infection Inflammation/Immunology
    Metronidazole hydrochloride (SC 326421) is an orally active nitroimidazole antibiotic, can be used to research anaerobic infections. Metronidazole hydrochloride can cross blood brain barrier and results inflammation and skeletal muscle contraction under long-term application .
    Metronidazole hydrochloride
  • HY-B0318R
    Metronidazole (Standard)

    		Bacterial Parasite Apoptosis Antibiotic Infection Inflammation/Immunology Cancer
    Metronidazole (Standard) is the analytical standard of Metronidazole. This product is intended for research and analytical applications. Metronidazole is an orally active nitroimidazole antibiotic. Metronidazole can cross blood brain barrier. Metronidazole can be used for the research of anaerobic infections .
    Metronidazole (Standard)
  • HY-138094
    N-(2-Hydroxyethyl)oxamic acid

    		Drug Metabolite Infection
    N-(2-hydroxyethyl)-oxamic acid is formed when Metronidazole is reduced either chemically or by the action of the intestinal bacteria. Metronidazole, a nitroimidazole antibiotic, has activity against various protozoans and most Gram-negative and Gram-positive anaerobic bacteria .
    N-(2-Hydroxyethyl)oxamic acid
  • HY-115249R
    Metronidazole acetic acid (Standard)

    		Parasite Antibiotic Bacterial Infection
    Metronidazole acetic acid (Standard) is the analytical standard of Metronidazole acetic acid. This product is intended for research and analytical applications. Metronidazole acetic acid is a metabolite of Metronidazole with mutagenic activity in bacteria. Metronidazole is a nitroimidazole antibiotic, amebicide, and antiprotozoal agent used particularly for anaerobic bacteria and protozoa .
    Metronidazole acetic acid (Standard)
  • HY-122288
    SC 28538

    		Bacterial Infection
    SC 28538 is a compound with antimicrobial activity. SC 28538 exerts its antimicrobial effect by reducing its nitro moiety in an anaerobic environment to form cytotoxic free radicals that can damage DNA and other key biomolecules of microorganisms .
    SC 28538
  • HY-P4725
    Abz-Thr-Ile-Nle-p-nitro-Phe-Gln-Arg-NH2

    		Fluorescent Dye Others
    Abz-Thr-Ile-Nle-p-nitro-Phe-Gln-Arg-NH2 is a fluorogenic substrate, that can be used for the fluorescence screening assay .
    Abz-Thr-Ile-Nle-p-nitro-Phe-Gln-Arg-NH2
  • HY-121648
    PK 130

    		Others Cancer
    PK 130 is a 2-nitroimidazole derivative that demonstrated potent hypoxic cellular radiosensitization in vitro as assessed by aerobic and hypoxic radiosensitivity of Chinese hamster V79 cells. PK 130 and PK 110 were more potent than SR-2508 at the same concentrations at 0.1 and 1.0 mM. The relative radiosensitization produced by PK 130 and PK 110 at 0.1 mM was comparable to that of 1.0 mM SR-2508. However, at 0.1 mM, the therapeutic effects of PK 130 and PK 110 were only modestly aerobic radiosensitizing. The relative radiosensitization of PK 130 and PK 110 at 0.1 mM was further enhanced by the reduction of glutathione (GSH) levels (less than 5% of control levels) by L-cysteine sulfoxide (BSO). The results of this study encourage the in vivo tumor radiosensitization evaluation of PK 130 and PK 110.
    PK 130
  • HY-158820
    Cosdosiran

    QPI-1007

    		 Small Interfering RNA (siRNA) Caspase Cardiovascular Disease
    Cosdosiran is a chemically modified siRNA designed to temporarily inhibit expression of the caspase 2 protein and can be used for the study of nonarteritic anterior ischemic optic neuropathy and other optic neuropathies such as glaucoma that result in the death of retinal ganglion cells.?
    Cosdosiran
  • HY-158820A
    Cosdosiran sodium

    QPI-1007 sodium

    		 Small Interfering RNA (siRNA) Caspase Cardiovascular Disease
    Cosdosiran sodium is a chemically modified siRNA designed to temporarily inhibit expression of the caspase 2 protein and can be used for the study of nonarteritic anterior ischemic optic neuropathy and other optic neuropathies such as glaucoma that result in the death of retinal ganglion cells.?
    Cosdosiran sodium

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: